Post-approval studies (Phase 4)Looking for participantsNCT07266558
What this trial is testing
Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)
Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 30,000